US Supreme Court Preview: Cases To Watch For Medtech
Executive Summary
A case before the Supreme Court this term will bring the five-year-old PTAB patent examination system into question, while two cases involving are being appealed for review. Of the pending cases, one involves a circuit split on what type of damages consumers must suffer to be allowed to sue medtech companies, while the other looks at the right of states to use outside counsel in suits against manufacturers.
You may also be interested in...
US Supreme Court Case Could End Patent Office Reexamination Procedure
The court has agreed to take an oil-industry case challenging patent office inter partes review procedures on the grounds they violate a constitutional right to trial by jury. IPRs have become an increasingly common approach in medtech and elsewhere for challenging patents outside of court, but not without controversy.
Unlocking Legalities: To Change How Courts View 510(k) Clearances, Industry Seeks 'Supreme' Support
Medtech's legal realm wants the US Supreme Court to correct the record on 510(k)s next term, and they say they've found the right case to make that happen: a J&J/Ethicon mesh device suit where the lower court refused to let the jury hear any mention at all of US FDA or the product's 510(k) clearance. Courts say 510(k)s lack sufficient relevance to support a company's case for product safety, but industry says that view is based on outdated facts and is fundamentally unfair.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.